Salem Investment Counselors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Salem Investment Counselors's OGN Position: Q2 2026 in Review
Salem Investment Counselors reduced its Organon & Co (OGN) stake by 0.37% in Q2 2026, selling an estimated $72 and leaving 1,598 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #760.
Salem Investment Counselors first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $798K in Q2 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Salem Investment Counselors held 1,598 shares of Organon & Co worth $21.6K as of Q2 2026.
- Salem Investment Counselors sold 6 Organon & Co shares in Q2 2026, an estimated $72.
- Organon & Co made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #760 holding.
- Salem Investment Counselors first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- Salem Investment Counselors's Organon & Co position peaked at $798K in Q2 2021.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.